Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 210

1.

Insomnia and hypertension: A misty landscape.

Stavropoulos K, Imprialos KP, Doumas M, Karagiannis A, Papademetriou V.

J Clin Hypertens (Greenwich). 2019 Mar 15. doi: 10.1111/jch.13519. [Epub ahead of print] No abstract available.

2.

Mineralocorticoid receptor antagonists in primary aldosteronism.

Stavropoulos K, Papadopoulos C, Koutsampasopoulos K, Lales G, Mitas C, Doumas M.

Curr Pharm Des. 2019 Mar 11. doi: 10.2174/1381612825666190311130138. [Epub ahead of print]

PMID:
30854950
3.

Now That Renal Denervation Works, How Do We Proceed?

Papademetriou V, Stavropoulos K, Doumas M, Tsioufis K.

Circ Res. 2019 Mar;124(5):693-695. doi: 10.1161/CIRCRESAHA.119.314695. No abstract available.

PMID:
30817252
4.

Time to rethink the role of sodium-glucose co-transporter 2 inhibitors in the elderly.

Patoulias D, Stavropoulos K, Imprialos K, Doumas M.

Pol Arch Intern Med. 2019 Feb 28;129(2):143-144. doi: 10.20452/pamw.4469. Epub 2019 Feb 28. No abstract available.

5.

Understanding the cardiovascular risk with non-insulin antidiabetic drugs.

Athyros VG, Imprialos K, Stavropoulos K, Sahinidis A, Doumas M.

Expert Opin Drug Saf. 2019 Feb 27:1-11. doi: 10.1080/14740338.2019.1586881. [Epub ahead of print]

PMID:
30810055
6.

Orthostatic hypertension: From pathophysiology to clinical applications and therapeutic considerations.

Magkas N, Tsioufis C, Thomopoulos C, Dilaveris P, Georgiopoulos G, Doumas M, Papadopoulos D, Tousoulis D.

J Clin Hypertens (Greenwich). 2019 Mar;21(3):426-433. doi: 10.1111/jch.13491. Epub 2019 Feb 6. Review.

7.

The Role of Statins in the Management of Nonalcoholic Fatty Liver Disease.

Doumas M, Imprialos K, Dimakopoulou A, Stavropoulos K, Binas A, Athyros VG.

Curr Pharm Des. 2018;24(38):4587-4592. doi: 10.2174/1381612825666190117114305.

PMID:
30652643
8.

Novel Data on the Prevalence, Identification, Scouting, and Treatment of Familial Hypercholesterolaemia.

Doumas M, Imprialos K, Stavropoulos K, Athyros VG.

Curr Pharm Des. 2018;24(31):3597-3598. doi: 10.2174/138161282431181224144112.

PMID:
30642238
9.

Slowed sensory reweighting and postural illusions in older adults: the moving platform illusion.

Craig CE, Doumas M.

J Neurophysiol. 2019 Feb 1;121(2):690-700. doi: 10.1152/jn.00389.2018. Epub 2018 Dec 12.

PMID:
30540502
10.

Metabolic syndrome: joint diagnostic criteria and links with comorbidities.

Katsiki N, Doumas M, Athyros V.

Hormones (Athens). 2018 Oct 27. doi: 10.1007/s42000-018-0074-9. [Epub ahead of print] No abstract available.

PMID:
30368688
11.

Putting proprioception for balance to the test: Contrasting and combining sway referencing and tendon vibration.

Doumas M, Valkanidis TC, Hatzitaki V.

Gait Posture. 2019 Jan;67:201-206. doi: 10.1016/j.gaitpost.2018.10.012. Epub 2018 Oct 19.

PMID:
30368206
12.

Drugs that Mimic the Effect of Gene Mutations for the Prevention or the Treatment of Atherosclerotic Disease: From PCSK9 Inhibition to ANGPTL3 Inactivation.

Athyros VG, Katsiki N, Dimakopoulou A, Patoulias D, Alataki S, Doumas M.

Curr Pharm Des. 2018;24(31):3638-3646. doi: 10.2174/1381612824666181009100517.

PMID:
30306859
13.

Chlorinated and brominated bisphenol A derivatives: Synthesis, characterization and determination in water samples.

Doumas M, Rouillon S, Venisse N, Nadeau C, Pierre Eugene P, Farce A, Chavatte P, Dupuis A, Migeot V, Carato P.

Chemosphere. 2018 Dec;213:434-442. doi: 10.1016/j.chemosphere.2018.09.061. Epub 2018 Sep 12.

PMID:
30243209
14.

Early Vascular Aging Risk Assessment From Ambulatory Blood Pressure Monitoring: The Early Vascular Aging Ambulatory Score.

Antza C, Doundoulakis I, Akrivos E, Stabouli S, Trakatelli C, Doumas M, Kotsis V.

Am J Hypertens. 2018 Oct 15;31(11):1197-1204. doi: 10.1093/ajh/hpy115.

PMID:
30239585
15.

SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature.

Patoulias D, Imprialos K, Stavropoulos K, Athyros V, Doumas M.

Curr Clin Pharmacol. 2018;13(4):261-272. doi: 10.2174/1574884713666180807150509.

PMID:
30084335
16.

Sodium-glucose Co-transporters 2 Inhibitors: The Miraculous Route from Hypoglycemic to Cardiovascular Drugs.

Imprialos KP, Stavropoulos K, Doumas M.

Cardiovasc Hematol Disord Drug Targets. 2018;18(2):83-85. doi: 10.2174/1871529X1802180628114731. No abstract available.

PMID:
30009694
17.

Computed Tomography and Adrenal Venous Sampling in the Diagnosis of Unilateral Primary Aldosteronism.

Williams TA, Burrello J, Sechi LA, Fardella CE, Matrozova J, Adolf C, Baudrand R, Bernardi S, Beuschlein F, Catena C, Doumas M, Fallo F, Giacchetti G, Heinrich DA, Saint-Hilary G, Jansen PM, Januszewicz A, Kocjan T, Nishikawa T, Quinkler M, Satoh F, Umakoshi H, Widimský J Jr, Hahner S, Douma S, Stowasser M, Mulatero P, Reincke M.

Hypertension. 2018 Sep;72(3):641-649. doi: 10.1161/HYPERTENSIONAHA.118.11382.

PMID:
29987100
18.

Combination of SGLT-2 Inhibitors and GLP-1 Receptor Agonists: Potential Benefits in Surrogate and Hard Endpoints.

Doumas M, Imprialos Κ, Stavropoulos K, Reklou A, Sachinidis A, Athyros VG.

Curr Pharm Des. 2018;24(17):1879-1886. doi: 10.2174/1381612824666180604113653.

PMID:
29865997
19.

Diabetes and lipid metabolism.

Athyros VG, Doumas M, Imprialos KP, Stavropoulos K, Georgianou E, Katsimardou A, Karagiannis A.

Hormones (Athens). 2018 Mar;17(1):61-67. doi: 10.1007/s42000-018-0014-8. Epub 2018 Apr 16. Review.

PMID:
29858856
20.

Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?

Reklou A, Doumas M, Imprialos K, Stavropoulos K, Patoulias D, Athyros VG.

Open Cardiovasc Med J. 2018 Mar 30;12:29-40. doi: 10.2174/1874192401812010029. eCollection 2018. Review.

Supplemental Content

Loading ...
Support Center